Ticker League

Net Profit Margin for Regeneron Pharmaceuticals (REGN)

As of · Reported

Metric

TTM

29.6%

YoY change

+0.34pp

Trough year (2002)

-565.7%

Peak year (2012)

54.4%

Net Profit Margin history chart for Regeneron Pharmaceuticals (REGN) from 1990 to 2025

Latest: 31.4%

Net Profit Margin change chart for Regeneron Pharmaceuticals (REGN) from 1990 to 2025

Latest: +0.34pp

Net Profit Margin history table for Regeneron Pharmaceuticals (REGN) from 1990 to 2025

  • 202531.4%+0.34pp
  • 202431.1%+0.93pp
  • 202330.1%-5.50pp
  • 202235.6%-14.61pp
  • 202150.2%+8.90pp
  • 202041.3%+9.08pp
  • 201932.3%-4.16pp
  • 201836.4%+16.02pp
  • 201720.4%+1.99pp
  • 201618.4%+2.93pp
  • 201515.5%+3.15pp
  • 201412.3%-7.82pp
  • 201320.2%-34.27pp
  • 201254.4%+104.17pp
  • 2011-49.7%-26.99pp
  • 2010-22.8%-4.87pp
  • 2009-17.9%+16.80pp
  • 2008-34.7%+49.78pp
  • 2007-84.5%+76.83pp
  • 2006-161.3%-17.10pp
  • 2005-144.2%-168.16pp
  • 200424.0%+210.86pp
  • 2003-186.9%+378.77pp
  • 2002-565.7%-218.96pp
  • 2001-346.7%-307.53pp
  • 2000-39.2%+27.79pp
  • 1999-67.0%-44.44pp
  • 1998-22.5%+12.53pp
  • 1997-35.0%+99.39pp
  • 1996-134.4%-48.67pp
  • 1995-85.8%+46.56pp
  • 1994-132.3%+244.09pp
  • 1993-376.4%-210.33pp
  • 1992-166.1%-104.44pp
  • 1991-61.6%+4.36pp
  • 1990-66.0%—

Net Profit Margin values are taken from Regeneron Pharmaceuticals's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Net Profit Margin at Regeneron Pharmaceuticals (REGN)

According to Regeneron Pharmaceuticals's latest reported financial statements, the company's latest reported net margin is 29.6%. Net profit margin is net income divided by revenue — the bottom-line share of each sales dollar that remains after all costs, including operating expenses, interest, and taxes. It is the most comprehensive profitability ratio, though it can swing on one-off items, so read it alongside the multi-year trend below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

In 2025, Regeneron Pharmaceuticals (REGN) net margin totalled 31.41% – expanded 0.3 percentage points year-over-year.

The highest annual net margin of 54.43% was reported in 2012. The lowest in the available history was -565.66% in 2002.

Regeneron Pharmaceuticals Net Profit Margin by Year

Regeneron Pharmaceuticals Net Profit Margin 2025: 31.4%

Regeneron Pharmaceuticals net margin in 2025 was 31.41%, expanded 0.3 percentage points from 2024.

Regeneron Pharmaceuticals Net Profit Margin 2024: 31.1%

2024's net margin for Regeneron Pharmaceuticals came in at 31.07%, expanded 0.9 percentage points from 2023.

Regeneron Pharmaceuticals Net Profit Margin 2023: 30.1%

Regeneron Pharmaceuticals posted net margin of 30.14% in 2023, contracted 5.5 percentage points from 2022.

Regeneron Pharmaceuticals Net Profit Margin 2022: 35.6%

In 2022, Regeneron Pharmaceuticals reported net margin of 35.64%, contracted 14.6 percentage points from 2021.

Regeneron Pharmaceuticals Net Profit Margin 2021: 50.2%

Regeneron Pharmaceuticals net margin in 2021 was 50.25%.

See more financial history for Regeneron Pharmaceuticals (REGN).

Sector peers by Net Profit Margin

Healthcare peers of Regeneron Pharmaceuticals (REGN), ranked by their latest net margin

Frequently asked questions

Regeneron Pharmaceuticals (REGN) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation